PDPN and arthropathy: These results indicate that SF-FLSs from JIA patients with active joint disease are CD45−CD34−THY+PDPN+, consistent with the phenotype reported for the SL-FLS population in the SM (12; 13) and for SF-FLSs from RA patients [16].